| Adverse events, including death, associated with the use of 1, 4-butanediol DL Zvosec, SW Smith, JR McCutcheon, J Spillane, BJ Hall, EA Peacock New England Journal of Medicine 344 (2), 87-94, 2001 | 263 | 2001 |
| Case series of 226 γ-hydroxybutyrate–associated deaths: lethal toxicity and trauma DL Zvosec, SW Smith, T Porrata, AQ Strobl, JE Dyer The American journal of emergency medicine 29 (3), 319-332, 2011 | 165 | 2011 |
| Three deaths associated with use of Xyrem® DL Zvosec, SW Smith, BJ Hall Sleep medicine 10 (4), 490-493, 2009 | 70 | 2009 |
| Agitation is common in γ-hydroxybutyrate toxicity DL Zvosec, SW Smith The American journal of emergency medicine 23 (3), 316-320, 2005 | 40 | 2005 |
| Physostigmine for gamma-hydroxybutyrate coma: inefficacy, adverse events, and review DL Zvosec, SW Smith, R Litonjua, REJ Westfal Clinical toxicology 45 (3), 261-265, 2007 | 35 | 2007 |
| Electrocardiographic diagnosis of acute coronary occlusion myocardial infarction in ventricular paced rhythm using the modified Sgarbossa criteria KW Dodd, DL Zvosec, MA Hart, G Glass III, LE Bannister, RM Body, ... Annals of Emergency Medicine 78 (4), 517-529, 2021 | 29 | 2021 |
| Gamma-hydroxybutyric acid. JO Sass, A Superti-Furga The New England journal of medicine 353 (15), 1632-1633, 2005 | 9 | 2005 |
| Gamma hydroxybutyrate (GHB) dependence and withdrawal D Zovsec, S Smith UpToDate online. Edited by Traub SJ, 2012 | 5 | 2012 |
| Commenting on" a review of tolerability and abuse liability of gamma-hydroxybutyric acid for insomnia in patients with schizophrenia," by Kantrowitzet al. DL Zvosec, SW Smith Clinical Therapeutics 32 (4), 780-785, 2010 | 5 | 2010 |
| Comment on" The abrupt cessation of therapeutically administered sodium oxybate (GHB) may cause withdrawal symptoms". DL Zvosec, SW Smith Journal of toxicology. Clinical toxicology 42 (1), 121-3; author reply 125, 2004 | 5 | 2004 |
| Unsupported “Efficacy” Claims of Gamma Hydroxybutyrate (GHB) DL Zvosec, SW Smith Academic Emergency Medicine 10 (1), 95-96, 2003 | 5 | 2003 |
| Adverse events associated with ingestion of gamma-butyrolactone-Minnesota, New Mexico, and Texas, 1998-1999 (Reprinted from MMWR, vol 48, pg 137-140, 1999) SW Smith, AR Topliff, M Danigelis, DL Zvosec, LL Schrag, SA Freiwald, ... JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 281 (11), 979-980, 1999 | 5 | 1999 |
| P103: Performance characteristics of the modified Sgarbossa criteria for diagnosis of acute coronary occlusion in emergency department patients with ventricular paced rhythm … GJ Mitchell, K Dodd, DL Zvosec, E Chen, MA Hart, J Marshall, AA Smith, ... Canadian Journal of Emergency Medicine 20 (S1), S93-S93, 2018 | 4 | 2018 |
| γ-Hydroxybutyrate addiction and withdrawal: from the γ-Hydroxybutyrate addiction study DL Zvosec, SW Smith Annals of Emergency Medicine 44 (4), S91, 2004 | 4 | 2004 |
| Gamma hydroxybutyrate (GHB) intoxication DL Zvosec, SW Smith, RG Hendrickson UpToDate online, 2012 | 3 | 2012 |
| Response to Editorial:" Xyrem safety: The debate continues". DL Zvosec, SW Smith Sleep medicine 11 (1), 108; author reply 108-9, 2009 | 3 | 2009 |
| 226 gamma hydroxybutyrate (GHB)-associated fatalities: overlap of postmortem GHB levels with endogenous, therapeutic, and non-fatal GHB toxicity cases and factors supporting … D Zvosec, SW Smith, T Porrata, AQ Strobl, JE Dyer Annual Meeting of the National Association of Medical Examiners. Savannah, GA, 2007 | 3 | 2007 |
| Use of propofol for severe GHB withdrawal: Two cases TJ Wiegand, DL Zvosec, SW Smith Journal of Toxicology: Clinical Toxicology 43 (6), 665, 2005 | 3 | 2005 |
| Gamma hydroxybutyrate (GHB) withdrawal and dependence DL Zvosec, SW Smith UpToDate. UpToDate, 2022 | 2 | 2022 |
| Further research on Xyrem®/sodium oxybate treatment of patients with obstructive sleep apnea is needed DL Zvosec, SW Smith, MW Mahowald Sleep and Breathing 15, 619-620, 2011 | 2 | 2011 |
Stephen W. SmithHennepin County Medical Center, University of MinnesotaVerified email at umn.edu
